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LETTERS TO THE EDITOR
Sex ratios as markers for hormone levels in cancer
Sir - There are a number of cancers (e.g. of the breast,
prostate, testicle, ovary, endometrium etc) which are sus-
pected or known to be hormonally caused. In principle, it is
difficult to obtain direct prospective data to test such hypo-
theses; and epidemiologists have accordingly searched for
markers of these hormone levels prior to initiation of the
disease. So, for example, with regard to cancers suspected of
being caused by oestrogens, efforts have been made to relate
the disease to age at menarche and age at menopause.
I wish to suggest that sex ratios (of sibs and offspring of
probands) comprise a largely unexploited source of such
markers. There is now a very large quantity of evidence
tending to support the hypothesis that the sex of human (and
other mammalian) offspring is affected by parental hormone
levels at the time of conception, high levels of oestrogen and
testosterone being associated with subsequent male births,
and high levels of gonadotrophin and progesterone with
subsequent female births (James, 1987a; 1989; 1990).
I shall first suggest that the sex ratios of relatives of
probands with three forms of cancer act satisfactorily as
markers for the hormones hypothesised to cause (or be
associated with) those cancers.
A. Non-Hodgkin's lymphoma
Olsson (1984) reported that men with malignant lymphomas
have low plasma testosterone levels and high serum LH levels
before treatment. Olsson & Brandt (1982) reported that the
sex ratio (proportion of males) of offspring of men with
non-Hodgkin's lymphoma was significantly low (P<.0005).
I suggest that this low sex ratio reflects the known pre-
treatment hormonal profile of these patients (and may thus
reflect a causal antecedent of this cancer).
B. Prostatic cancer
There can be no reasonable doubt that androgens play a part
in the aetiology of this disease (Flanders, 1984). There are
three sets of data on the sex ratio of offspring of men who
subsequently develop the disease. The first relates to data
pooled from three Canadian studies (James, 1987b); and the
other two relate to samples of patients in Los Angeles
(James, 1990). In two of these three sets ofdata the sex ratios
of offspring were significantly high (P<.05): and the Poisson
probability of two events (or three) out of three occurring
(by chance) at the .05 level is .01. I suggest that this high sex
ratio can be regarded as a marker for the high androgen
levels thought to have causal effects in prostatic cancer.
C. Testicular cancer
It has been hypothesised that intrauterine exposure to high
maternal levels of oestrogen predispose male offspring to
develop testicular cancer (Swerdlow et al., 1987). These
authors also reported that cases had an excess of brothers
(significant in respect of probands with seminoma). I suggest
that high levels of pregnancy oestrogens are experienced by
women who have high oestrogen levels at other times too.
And that this high oestrogen level at the time of conception
is responsible for the excess of males produced by these
women. In other words, if I am correct, the excess of
brothers acts as a marker for the high intrauterine oestrogen
levels hypothesised to cause the cancer.
If the above line of reasoning were accepted, then sex
ratios might usefully be employed as tests of other hormonal
hypotheses of cancer. The table offers sex ratio tests of three
different sorts ofcancer. It is likely that some of the biases in
sex ratios occasioned by abnormal hormone levels associated
with the various cancers are not large; so substantial quan-
tities of such data may be needed to test the relevant
hypotheses. Since some of the cancers are comparatively rare,
it would be useful if a clearing-house could be set up to
monitor such data. Meanwhile I urge workers with data on
the sexes of sibs and offspring of cancer probands to contact
me.
yours etc,
W.H. James
MRC Mammalian Development Unit,
Wolfson House,
(University College London),
4 Stephenson Way,
London NW1 2HE, UK.
Table I Sex ratios that would test hypothesised hormonal causes of cancer
Suggestedsex ratio
In utero as marker
Cancer Hormone or self Relative High or Low Reference
Breast Oestrogen In utero Sibs High Trichopoulos, 1990
Ovarian germ cell Oestrogen In utero Sibs High Walker et al., 1988
Endometrium Oestrogen Self Offspring High Persson et al., 1989
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